Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Accipiter Capital Management is a New York-based investment firm that specializes in the healthcare and life sciences sectors. Founded in 2002 by Gabe Hoffman, the firm manages hedge funds and private investments with a focus on biotechnology, pharmaceuticals, and medical devices. Accipiter employs a fundamental, research-driven strategy to identify high-growth opportunities and undervalued assets within the global healthcare market. The firm is known for its deep industry knowledge and its role as a long-term investor in both emerging and established healthcare companies. By leveraging extensive scientific and financial expertise, Accipiter aims to generate superior returns through targeted investments in medical innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Accipiter Capital Management.